Nicotine

DB00184ApprovedInvestigationalSmall moleculeCholinergic Nicotinic Agonist

Nicotine is a stimulatory alkaloid found in tobacco products that is often used for the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission.

Chemical structure of Nicotine
Mechanism
Curator reviewed
Primary indication
For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.Curator reviewed · 1 structured indication
Formula / weight
C10H14N2 · 162.2316 g/mol (avg)
First approval
Canada, 2011 · United States, 1990
Also known as
(S)-Nicotine · Nicotine betadex · Nicotine polacrilex
Brand names
  • Habitrol
  • Nicoderm C-Q
  • Nicorelief
  • Nicorette
  • Nicotrol

Resolves to

Structure
InChIKeySNICXCGAKADSCV-JTQLQIEISA-NSMILESCN1CCC[C@H]1C1=CN=CC=C1

What you can answer from here — as of September 29, 2026

13Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5TransportersSubstrate / inhibitor direction, not just membership
Listed above
731Drug interactionsStructured to mechanism, not free text
Sign in
505Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1,843Marketed productsAcross 9 countries and 152 labellers
Sign in
1ATC codeIncluding every combination product, plus 44 drug categories
Sign in
104+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nicotine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account